Providers can eliminate the use of gadolinium-based contrast by using new pulse sequences from Toshiba America Medical Systems. The angiography techniques rely on differences in the MR signal that distinguish blood and surrounding soft tissue.
Providers can eliminate the use of gadolinium-based contrast by using new pulse sequences from Toshiba America Medical Systems. The angiography techniques rely on differences in the MR signal that distinguish blood and surrounding soft tissue. The company showcased Fresh Blood Imaging, Contrast-free Improved Angiography, and Time-spatial Labeling Inversion Pulse, positioning these contrast-free imaging techniques as alternatives to gadolinium-based agents. The use of such agents has been associated with the occurrence of nephrogenic systemic fibrosis.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.
Can MRI-Based Deep Learning Improve Risk Stratification in PI-RADS 3 Cases?
January 30th 2025In external validation testing, a deep learning model demonstrated an average AUC of 87.6 percent for detecting clinically significant prostate cancer (csPCA) on prostate MRI for patients with PI-RADS 3 assessments.